Total Funding
74
75
Total FundingPost-IPO Equity raised
Growth Score
-11 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
5998
Natera specializes in cell-free DNA testing to provide a more targeted interventions to oncology, women's health, and organ health.
- Matthew Rabinowitz: CEO, Co-Founder & Executive ChairmanPast Role: Rosum, Founder, CTO and CTO
Ravi Mhatre: InvestorPast Role: Highfive, Investor
About the Company
Natera specializes in cell-free DNA testing and is driven by a passion for elevating the science and utility of prenatal testing. The advent of the Information Age has created a paradigm shift in the fields of computing and informatics. Surprisingly, medical diagnostics have been slow to integrate these advances into genetic testing.
